This article was originally published in The Gray Sheet
Executive SummaryNext-generation Vitality ICD offers new rhythm discrimination technology to manage complex arrhythmias, Guidant claims in Oct. 1 release announcing European launch. The 30 cc Vitality is the "smallest" and thinnest ICD on the market, Guidant says. The new algorithms allow physicians to pinpoint the origin of the arrhythmia and "quickly" program the most appropriate therapy...
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.